Pitroda SP, Bao R, Andrade J, Weichselbaum RR, Connell PP: Low Recombination Proficiency Score (RPS) predicts heightened sensitivity to DNA-damaging chemotherapy in breast cancer. Clin Cancer Res. 2017 Aug 1;23(15):4493-4500. - Stand Up To Cancer

Blog

Posted October 7, 2019

Pitroda SP, Bao R, Andrade J, Weichselbaum RR, Connell PP: Low Recombination Proficiency Score (RPS) predicts heightened sensitivity to DNA-damaging chemotherapy in breast cancer. Clin Cancer Res. 2017 Aug 1;23(15):4493-4500.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.